Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis
出版年份 2023 全文链接
标题
Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis
作者
关键词
-
出版物
NATURE BIOTECHNOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-02-24
DOI
10.1038/s41587-023-01680-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation
- (2022) Marijana Vujkovic et al. NATURE GENETICS
- Current therapies and new developments in NASH
- (2022) Jean-François Dufour et al. GUT
- Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice
- (2022) Mohammad Kabbani et al. Cell Reports
- How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
- (2021) Yana Geng et al. Hepatology International
- Diagnosis and management of secondary causes of steatohepatitis
- (2021) Roman Liebe et al. JOURNAL OF HEPATOLOGY
- Therapeutic pipeline in nonalcoholic steatohepatitis
- (2021) Raj Vuppalanchi et al. Nature Reviews Gastroenterology & Hepatology
- Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
- (2021) Amedeo Lonardo et al. ADVANCES IN THERAPY
- Mechanisms and disease consequences of nonalcoholic fatty liver disease
- (2021) Rohit Loomba et al. CELL
- Ablation of fatty acid desaturase 2 (FADS2) exacerbates hepatic triacylglycerol and cholesterol accumulation in polyunsaturated fatty acid‐depleted mice
- (2021) Yuri Hayashi et al. FEBS LETTERS
- FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption
- (2021) Bethan L. Clifford et al. Cell Metabolism
- Modelling PNPLA3‐Associated Non‐Alcoholic Fatty Liver Disease Using Human Induced Pluripotent Stem Cells
- (2021) Samantha G. Tilson et al. HEPATOLOGY
- Dietary carbohydrates and fats in nonalcoholic fatty liver disease
- (2021) Hannele Yki-Järvinen et al. Nature Reviews Gastroenterology & Hepatology
- Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
- (2021) Mojgan Masoodi et al. Nature Reviews Gastroenterology & Hepatology
- Therapeutic landscape for NAFLD in 2020
- (2020) Brent A. Neuschwander-Tetri GASTROENTEROLOGY
- Fast and efficient generation of knock-in human organoids using homology-independent CRISPR–Cas9 precision genome editing
- (2020) Benedetta Artegiani et al. NATURE CELL BIOLOGY
- Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages
- (2020) Sander Lefere et al. JOURNAL OF HEPATOLOGY
- Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis
- (2020) Tracey Hurrell et al. Cells
- Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease
- (2020) Muhammad Nadzim Bin Ramli et al. GASTROENTEROLOGY
- A web tool for the design of prime-editing guide RNAs
- (2020) Ryan D. Chow et al. Nature Biomedical Engineering
- Establishment of human fetal hepatocyte organoids and CRISPR–Cas9-based gene knockin and knockout in organoid cultures from human liver
- (2020) Delilah Hendriks et al. Nature Protocols
- FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
- (2020) Emma Henriksson et al. Frontiers in Endocrinology
- Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis
- (2019) Soumik BasuRay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
- (2019) Daniel Lindén et al. Molecular Metabolism
- Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids
- (2019) Rie Ouchi et al. Cell Metabolism
- Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism
- (2019) Alexandra Collin de l’Hortet et al. Cell Metabolism
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
- (2019) Mohammed Eslam et al. Nature Reviews Gastroenterology & Hepatology
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- Human hepatic 3D spheroids as a model for steatosis and insulin resistance
- (2018) Mikael Kozyra et al. Scientific Reports
- Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
- (2018) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
- (2018) Huili Hu et al. CELL
- Non-alcoholic fatty liver disease – A global public health perspective
- (2018) Zobair M. Younossi JOURNAL OF HEPATOLOGY
- Perilipins: a diversity of intracellular lipid droplet proteins
- (2017) Hiroyuki Itabe et al. Lipids in Health and Disease
- Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide
- (2017) Mikhaïl Van Herck et al. Nutrients
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis
- (2015) Hiroshi Tsugawa et al. NATURE METHODS
- Hypobetalipoproteinemia and abetalipoproteinemia
- (2014) Francine K. Welty CURRENT OPINION IN LIPIDOLOGY
- Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study
- (2014) Juanwen Zhang et al. Scientific Reports
- Obesity resistance and deregulation of lipogenesis in Δ6-fatty acid desaturase (FADS2) deficiency
- (2013) Wilhelm Stoffel et al. EMBO REPORTS
- Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
- (2013) Jennifer E. Lambert et al. GASTROENTEROLOGY
- Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis
- (2013) Cristina López-Vicario et al. GUT
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial
- (2012) Helena Bjermo et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis
- (2012) John Zhong Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
- (2012) Carlo Pirazzi et al. JOURNAL OF HEPATOLOGY
- The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2
- (2012) Jenson Qi et al. JOURNAL OF LIPID RESEARCH
- Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
- (2011) Eric T. Sawey et al. CANCER CELL
- Secondary causes of nonalcoholic fatty liver disease
- (2011) Jacob M. Kneeman et al. Therapeutic Advances in Gastroenterology
- Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease
- (2010) Weiqin Chen et al. HEPATOLOGY
- Lipidomics reveals a remarkable diversity of lipids in human plasma,
- (2010) Oswald Quehenberger et al. JOURNAL OF LIPID RESEARCH
- Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver
- (2008) A. Kotronen et al. DIABETES
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
- Common variants at 30 loci contribute to polygenic dyslipidemia
- (2008) Sekar Kathiresan et al. NATURE GENETICS
- Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
- (2008) Yurii S Aulchenko et al. NATURE GENETICS
- Abetalipoproteinemia: two case reports and literature review
- (2008) Rola Zamel et al. Orphanet Journal of Rare Diseases
- Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
- (2008) Harmeet Malhi et al. SEMINARS IN LIVER DISEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now